Home
|
About
|
Quick Start
|
FAQ
Beta Version 0.1
DHARA is an online index of articles on Ayurveda published in research journals worldwide.
Users Online:
102
Unfiltered
Classified Search
Enter Keyword Below :
Advanced
Journal of Ayurveda and Integrative medicine
2022
January- March
;
13
(1)
:100463
[Epub ahead of Print]
Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression
Vedika Bhat (1)
,
Vedika Bhat (1)
,
Swapnil Borse (1)
,
Swapnil Borse (1)
,
Preeti Chavan-Gautam (1)
,
Preeti Chavan-Gautam (1)
,
Kalpana Joshi (2)
,
Kalpana Joshi (2)
1. AYUSH - Center of Excellence, Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, 411 007, India 2. Department of Biotechnology, Sinhgad College of Engineering, Affiliated to SPPU, Pune, 411041, India. Electronic address: joshikalpana@gmail.com.
Abstract
Recent reports on COVID-19 suggest that, the susceptibility to COVID-19 infection and its progression have a genetic predisposition. Majorly associated genetic variants are found in human leukocyte antigen (HLA), angiotensin convertase enzyme (ACE; rs1799752: ACE2; rs73635825), and transmembrane protease serine 2 (TMPRSS-2; rs12329760) genes. Identifying highly prone population having these variants is imperative for determining COVID-19 therapeutic strategies. Ayurveda (Indian traditional system of medicine) concept of Prakriti holds potential to predict genomic and phenotypic variations. Reported work on Prakriti correlates HLA-DR alleles with three broad phenotypes (Tridosha) described in Ayurveda (AyuGenomics). This is suggestive of differences in immune responses in individuals with specific constitutions. Therefore, the reported studies provide clues for clinically relevant hypotheses to be tested in systematic studies. The proposed approach of Ayurveda-based phenotype screening may offer a way ahead to design customized strategies for management of COVID-19 based on differences in Prakriti, immune response, and drug response. However, this needs clinical evaluation of the relation between Prakriti and genetic or phenotypic variants in COVID-19 prone and resistant populations.
DHARA ID:
D058225
Pubmed ID:
34177193
Link To Full Paper
Copyright
|
Disclaimer
|
Feedback
|
Updates
|
Contact
Developed and maintained by AVP Research Foundation (Formerly AVT Institute for Advanced Research), 136/137, Trichy Road, Ramanathapuram, Coimbatore - 641045, Tamil Nadu, India
Funded by Central Council for Research in Ayurvedic Sciences, Dept. of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi